Results 151 to 160 of about 1,119,893 (198)
Expert Review of Pharmacoeconomics & Outcomes Research, 2019 Intravenous iron and erythropoiesis-stimulating agents are used to manage anemia in chronic hemodialysis patients. The interchangeability between intravenous iron sucrose preparations is still debated. We evaluated how cost and effectiveness were impacted when chronic hemodialysis patients were switched from an original iron sucrose product to an iron ...
Pagès, Arnaud +9 more
openaire +3 more sources
World Journal of Anemia, 2017 ABSTRACT Iron deficiency is a major worldwide health problem. There is recent evidence that anemia is the last manifestation of the syndrome. Advances in outlining the physiology of iron deficiency have been made; gaps remain in the current understanding.
KS Kavitha Gautham
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intravenous Iron Sucrose in Peritoneal Dialysis Patients with Renal Anemia
Peritoneal Dialysis International, 2008Objective To explore the safety and efficacy of intravenous (IV) iron sucrose in maintenance peritoneal dialysis (PD). Design Randomized, controlled, parallel-group single-center trial.
Shi-Xiang Wang
exaly +3 more sources
Hepatocellular Damage Following Therapeutic Intravenous Iron Sucrose Infusion in a Child
Therapeutic Drug Monitoring, 2005 The maximum tolerated single dose of intravenous iron infusion and iron pharmacokinetics are not known in children and not clear in adults. The case reported here is of a child given a large dose of intravenous iron sucrose (16 mg/kg) over 3 hours, who subsequently developed features of systemic iron toxicity. A TDM consultant discusses the case in the
Wood, D.M. +4 more
core +8 more sources
Intravenous iron sucrose for children with iron deficiency anemia: a single institution study
World Journal of Pediatrics, 2015Intravenous iron sucrose is not recommended by its manufacturers for use in children despite extensive safety and efficacy data in adults.We reviewed the experience of our department between January, 2011 and February, 2014 with the use of intravenous iron sucrose in children ≤14 years of age who failed in oral iron therapy for iron deficiency anemia ...
Elpis Mantadakis +1 more
exaly +3 more sources
Current Medical Research and Opinion, 2013
Severe iron deficiency resulting in anemia is a common problem during pregnancy and in menstruating women. Several choices for IV iron replacement therapies exist and increased pressures on budgets may require cheaper 'iron sucrose similar' (ISS) to be used.
Gyu Yeon Choi +2 more
exaly +3 more sources
Severe iron deficiency resulting in anemia is a common problem during pregnancy and in menstruating women. Several choices for IV iron replacement therapies exist and increased pressures on budgets may require cheaper 'iron sucrose similar' (ISS) to be used.
Gyu Yeon Choi +2 more
exaly +3 more sources
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose [PDF]
Journal of Perinatal Medicine, 2012 Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose.
Begoña Martinez de Tejada +2 more
exaly +5 more sources
Intravenous Iron Sucrose for Children With Iron Deficiency Anemia
Journal of Pediatric Hematology/Oncology, 2017Iron deficiency anemia (IDA) is the most common nutritional deficiency in children. Most children with IDA are treated with oral iron preparations. However, intravenous (IV) iron is an alternative for children with severe IDA who have difficulty in adhering to or absorbing oral iron. We sought to describe the safety and effectiveness of IV iron sucrose
Kristiyana, Kaneva +3 more
openaire +2 more sources
Differences Between Original Intravenous Iron Sucrose and Iron Sucrose Similar Preparations
Arzneimittelforschung, 2011Iron sucrose (Venofer; reference) has a good safety record and is prescribed in patients with anaemia and chronic kidney disease worldwide, but various iron sucrose similar (ISS) preparations are now utilized in clinical practice. This study evaluates possible differences between iron sucrose and ISS preparations on haemodynamic and oxidative stress ...
Jorge Eduardo, Toblli +3 more
openaire +2 more sources